1. Home
  2. SIDU vs CYCN Comparison

SIDU vs CYCN Comparison

Compare SIDU & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.25

Market Cap

243.4M

ML Signal

HOLD

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

N/A

Current Price

$4.15

Market Cap

16.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIDU
CYCN
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.4M
16.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SIDU
CYCN
Price
$2.25
$4.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3M
29.5K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
66.94
8.26
EPS
N/A
N/A
Revenue
$3,383,878.00
$2,074,000.00
Revenue This Year
$171.29
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.70
52 Week Low
$0.63
$1.03
52 Week High
$6.79
$8.48

Technical Indicators

Market Signals
Indicator
SIDU
CYCN
Relative Strength Index (RSI) 49.63 60.09
Support Level $1.73 $2.93
Resistance Level $2.67 $3.97
Average True Range (ATR) 0.19 0.36
MACD 0.01 0.01
Stochastic Oscillator 32.46 52.95

Price Performance

Historical Comparison
SIDU
CYCN

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: